 | Ascendis Pharma A/S | |||
| NMS : ASND || Location: Denmark | ||||
$142.1+1.93 (+1.38%) |
0.25 M | 140.41 - 144.33 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.347 M |
| March 15, 2024 | 2.943 M |
| Feb. 29, 2024 | 2.996 M |
| Feb. 15, 2024 | 2.967 M |
| Jan. 31, 2024 | 2.931 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -2.07 | -1.54 | 25.51% |
| 09/30/2023 | -2.43 | -2.88 | -18.71% |
| 06/30/2023 | -2.64 | -2.16 | 18.26% |
| 03/31/2023 | -2.71 | -1.98 | 27.04% |
| 12/31/2022 | -2.61 | -3.70 | -41.66% |
ASND Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 56.614M | Shares Float | 56.162M |
| Short Float | 3.347M | Market Cap | 8044.85M |
| Institution ownership | 0.00% | Insider ownership | 0.764% |
| Earnings Date | 04/25/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -9.13 | Forward EPS | -0.06 |